Head injury: Complications and management

Current Opinion in Anaesthesiology

Volumn 11, Issue 5, 1998, Pages 473-477

  Andrews, Peter J D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; NEUROPROTECTIVE AGENT;

ACUTE DISEASE; BRAIN FUNCTION; BRAIN INJURY; DRUG COST; HEAD INJURY; HEALTH CARE DELIVERY; HUMAN; HYPOTHERMIA; LUNG INJURY; MORTALITY; NEUROLOGICAL COMPLICATION; NEUROPROTECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW;

EID: 0031760329     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-199810000-00004     Document Type: Review

References (54)

1. Myseros JS, Bullock R. The rationale for glutamate antagonists in the treatment of traumatic brain injury. Ann NY Acad Sci 1995; 765:262-271.
2. Wagstaff A, Teasdale GM, Clifton G, Stewart L. The cerebral hemodynamic and metabolic effects of the noncompetitive NMDA antagonist CNS 1102 in humans with severe head injury. Ann NY Acad Sci 1995; 765:332-333.
3. Kehne JH, Kane JM, Chaney SF, Hurst G, McCloskey TC, Petty MA, et al. Preclinical characterization of MDL 27,192 as a potential broad spectrum anticonvulsant agent with neuroprotective properties. Epilepsy Res 1997; 27:41-54.
4. Fleishaker JC, Straw RN, Cross CJ. Pharmacokinetics of tinlazad and U-89678, an active, reduced metabolite, following acute head trauma in adults. J Pharmaceut Sci 1997; 86:434-437.
5. Chan TK, Wong JS, Ram RS, Amrith S. Visual recovery following treatment with very high dose corticosteroid in traumatic optic neuropathy. Singapore Med J 1996; 37:216-217.
6. Bullock R. Strategies for neuroprotection with glutamate antagonists. Extrapolating from evidence taken from the first stroke and head injury studies. Ann NY Acad Sci 1995; 765:272-278.
7. Verweij BH, Muizelaar JP. Avoiding secondary brain injury after severe head trauma: monitoring and management. J Cranio-Maxillofac Trauma 1996; 2:8-17.
8. Andrew PJD, Murugavel S, Deehan S. Conventional multimodality monitoring and failure to detect ischemic cerebral blood flow. J Neurosurg Anesthesiol 1996; 8:220-226.
9. Souter MJ, Andrews PJD. Validation of the Edslab dual lumen oximetry catheter for continuous monitoring of jugular bulb oxygen saturation after severe head injury. Br J Anaesth 1996; 76:744-746.
10. Feldman Z, Robertson CS. Monitoring of cerebral hemodynamics with jugular bulb catheters. Crit Care Clin 1997; 13:51-77.
11. Karaaslan T, Meuli R, Androux R, Duvoisin B, Hessler C, Schnyder P. Traumatic chest lesions in patients with severe head trauma: a comparative study with computed tomography and conventional chest roentgenograms. J Trauma-Inj Infect Crit Care 1995; 39:1081-1086.
12. Ziran BH, Le T, Zhou H, Fallon W, Wilber JH. The impact of the quantity of skeletal injury on mortality and pulmonary morbidity. J Trauma-Inj Infect Crit Care 1997; 43:916-921.
13. Atkinson JD, Bratton SL. Acute lung injury in isolated traumatic brain injury. Neurosurgery 1997; 41:1214-1216.
14. Bratton SL, Davis RL, Narayan RK, Rosner MJ, Marshall LF. Acute lung injury in isolated traumatic brain injury. Neurosurgery 1997; 40:707-712. In this retrospective analysis of the prospective traumatic coma data bank series, the authors did not find a relationship between CT scan lesions and ALI, but this may be due to the limited resolution of CT in the posterior fossa. Patients with diffuse brain swelling and mid-line shift or low GCS should be considered at high risk of ALI.
15. Simmons RL, Martin AM Jr, Heisterkamp CA 3rd, Ducker TB. Respiratory insufficiency in combat casualties. II. Pulmonary edema following head injury. Ann Surg 1969; 170:39-44.
16. Rogers FB, Shackford SR, Trevisani GT, Davis JW. Mackersie RC, Hoyt DB. Neurogenic pulmonary edema in fatal and nonfatal head injuries. J Trauma 1995; 39:860-866; discussion 866-868.
17. Beckman DL, Mehta P. Phentolamine-induced protection from neurogenic pulmonary oedema. Med Sci Res 1996; 24:847-848.
18. Chen HI. Hemodynamic mechanisms of neurogenic pulmonary edema. Biol Signals 1995; 4:186-192.
19. Kwiecinski H, Janik P, Szulc M. Neurogenic pulmonary edema: case report and analysis of pathogenesis. Neurolog Neurochirurg Polska 1996; 30:467-474.
20. Mayer SA, Limandri G, Sherman D, Lennihan L, Fink ME, Solomon RA, et al. Electrocardiographs markers of abnormal left ventricular wall motion in acute subarachnoid hemorrhage. J Neurosurg 1995; 83:889-896.
21. Smith WS, Matthay MA. Evidence for a hydrostatic mechanism in human neurogenic pulmonary edema. Chest 1997; 111:1326-1333. Alveolar oedema fluid was examined after bronchoscopy and the protein content compared with plasma protein concentration and expressed as a ratio. Data from the largest series of patients with NPE, in whom pulmonary oedema fluid was examined for protein content, suggest that hydrostatic mechanisms are the common pathophysiological mechanism for neurogenic pulmonary oedema in humans.
22. McKeating EG, Mascia L, Andrews PJD. Adhesion molecule concentrations in jugular venous and arterial serum after acute brain injury. Br J Anaesth 1997; 78:455-456.
23. McKeating EG, Andrews PJD, Signorini DFS, Mascia L. Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. Br J Anaesth 1997; 78:520-523.
24. McKeating EG, Andrews PJD. Cytokines and adhesion molecules in acute brain injury. Br J Anaesth 1998; 80:77-84.
25. McKeating EG, Andrews PJD, Signorini DF, Mascia L. Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. Br J Anaesth 1997; 78:520-523.
26. McKeating EG, Mascia L, Andrews PJD. Relation between systemic adhesion molecule concentrations and injury type, severity and outcome after acute brain injury. Eur J Anaesthesiol 1997; 14:544-545.
27. McKeating EG, Andrews PJD. Cytokines and adhesion molecules in acute brain injury. Br J Anaesth 1998; 80:77-84. In this study serum concentration of soluble sICAM-1 showed a strong relationship with outcome and was predictive if admission and 24 h measures were assessed. Neutrophil infiltration and cerebral oedema are related and a further pathophysiological mechanism may be mechanical obstruction or 'plugging' of the microvasculature as neutrophil adhesion and migration progresses.
28. Douzinas EE, Tsidemiadou PD, Pitaridis MT, Andrianakis I, Bobota-Chloraki A, Katsouyanni K, et al. The regional production of cytokines and lactate in sepsis-related multiple organ failure. Am J Respir Crit Care Med 1997; 155:53-59.
29. Reid PT, Donnelly SC, Haslett C. Inflammatory predictors for the development of the adult respiratory distress syndrome. Thorax 1995; 50:1023-1026.
30. Donnelly SC, Macgregor I, Zamani A, Gordon MG, Robertson CE, Steedman DJ, et al. Plasma elastase levels and the development of the adult respiratory distress syndrome. Am J Respir Crit Care Med 1995; 151:1428-1433.
31. 2O.
32. Deehan SC, Grant IS. Haemodynamic changes in neurogenic pulmonary oedema: effect of dobutamine. Intens Care Med 1996; 22:672-676.
33. Wells C, Cujec B, Johnson D, Goplen G. Reversibility of severe left ventricular dysfunction in patients with subarachnoid hemorrhage. Am Heart J 1995; 129:409-412.
34. 24 and the Acute Physiology and Chronic Health Evaluation II. Although the GCS can provide a quick guide to the assessment of severity of injury, only a comprehensive scoring system that includes physiology and chronic health variables will provide accurate discrimination and prediction of outcome in head injured patients. In this study MPM II performed well.
35. Griffin WT, Sheng JG, Royston MC, Gentleman SM, McKenzie JE, Graham DI, et al. Glial-neuronal interactions in Alzheimer's disease: the potential rote of a 'cytokine cycle' in disease progression. Brain Pathol 1998; 8:65-72.
36. Teasdale GM, Nicoll JR, Murray G, Fiddes H. Apolipoprotein E polymorphism: a genetic influence on outcome after head injury? Br J Neurosurg 1997; 11:483.
37. Teasdale GM, Nicoll JR, Murray G, Fiddes M. Association of apolipoprotein E polymorphism with outcome after head injury. Lancet 1997; 350:1069-1071. This study showed a significant genetic association between apoE polymorphism and outcome, supporting the hypothesis of a genetically determined influence. Patients with apoE4 are more than twice as likely to have an unfavourable outcome than those without the allele.
38. Dunn LT. Head injury therapies. Exp Opin Invest Drugs 1997; 6:1511-1526.
39. Grotta J and the US and Canadian Lubeluzole Ischemic Stroke Study Group. Lubeluzole treatment of acute ischemic stroke. Stroke 1997; 28:2338-2346.
40. Werner C. Mild and moderate hypothermia as a new therapeutic concept in the treatment of cerebral ischemia and of craniocerebral trauma-pathophysiological fundamentals. Anasthesiol, Intensivmed, Notfallmed, Schmerzther 1997; 32:210-218.
41. Clark RS, Carcillo JA, Kochanek PM, Obrist WD, Jackson EK, Mi Z, et al. Cerebrospinal fluid adenosine concentration and uncoupling of cerebral blood flow and oxidative metabolism after severe head injury in humans. Neurosurgery 1997; 41:1284-1292.
42. Marion DW. Therapeutic moderate hypothermia for severe traumatic brain injury. J Intens Care Med 1997; 12:239-248.
43. Piepgras A, Roth H, Schurer L, Tillmans R, Quintel M, Herrmann P, et al. Rapid active internal core cooling for induction of moderate hypothermia in head injury by use of an extracorporeal heat exchanger. Neurosurgery 1998; 42:311-318.
44. Hayashi S, Isayama K, Teramoto A. Anterior pituitary functions in patients with severe head injuries treated with moderate hypothermia. Brain Nerve 1997; 49:145-150.
45. Heegaard W, Biros M, Zink J. Effect of hypothermia, dichloroacetate, and deferoxamine in the treatment for cortical edema and functional recovery after experimental cortical impact in the rat. Acad Emerg Med 1997; 4:33-39.
46. Clark RS, Kochanek PM, Dixon CE, Chen M, Marion DW, Heineman S, et al. Early neuropathologic effects of mild or moderate hypoxemia after controlled cortical impact injury in rats. J Neurotrauma 1997; 14:179-189.
47. Shapira Y, Artru AA. Hypothermia to improve neurologic outcome after head injury in patients [1]. J Neurosurg Anesthesiol 1998; 10:55-56.
48. Marion DW, Penrod LE, Kelsey SF, Obrist WD, Kochanek PM, Palmer AM, et al. Treatment of traumatic brain injury with moderate hypothermia. N Engl J Med 1997; 336:540-546. Therapeutic moderate hypothermia was shown to cause a significant improvement in neurological outcomes 3, 6, and 12 months after injury for those patients with an initial GCS score of 5-7. The improvement in outcome for these patients was associated with a hypothermia-induced reduction of intracranial pressure and cerebrospinal fluid levels of IL-1β and glutamate.
49. Rosenfeld JV, Kaye AH, Leslie K. Hypothermia and severe trauma [letter; comment]. Aust NZ J Surg 1995; 65:80-85.
50. 2) in rats. Adv Exp Med Biol 1996; 388:191-195.
51. Rowbottom JR, Nearman H. Fluid replacement: crystalloid, colloid and hemoglobin substitutes. Progr Anesthesiol 1996; 10:315-331.
52. Kerr ME, Rudy EB, Weber BB, Stone KS, Turner BS, Orndoff PA, et al. Effect of short-duration hyperventilation during endotracheal suctioning on intracranial pressure in severe head-injured adults. Nursing Res 1997; 46:195-201.
53. Statham PFX, Andrews PJD. Central nervous system trauma. Baillières Clin Neurol 1996; 5:497-514.
54. Maas AR, Dearden M, Teasdale GM, Braakman R, Cohadon F, Iannotti F, et al. EBIC-Guidelines for management of severe head injury in adults. Acta Neurochirurg 1997; 139:286-294.